Stay updated on NIMBLe Study: Clinical Trial_hyperMutated Cancers
Sign up to get notified when there's something new on the NIMBLe Study: Clinical Trial_hyperMutated Cancers page.

Latest updates to the NIMBLe Study: Clinical Trial_hyperMutated Cancers page
- Check2 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed from the page.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check37 days agoChange Detected- Revision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision: v3.4.2 was added; the prior v3.4.1 notice was removed. These changes are limited to system-level updates and do not affect study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check73 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH operations. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check80 days agoChange DetectedAdded a glossary toggle and new metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new revision tag 'v3.4.0'. The previous label variants 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' and the older revision 'v3.3.4' were removed.SummaryDifference0.2%

Stay in the know with updates to NIMBLe Study: Clinical Trial_hyperMutated Cancers
Enter your email address, and we'll notify you when there's something new on the NIMBLe Study: Clinical Trial_hyperMutated Cancers page.